‘Difficult period’ for emerging markets
Ongoing crises in China such as Evergrande have meant American Century are neutral on emerging markets (EMs) but vaccine accessibility is a reason for optimism.
In an investment outlook, Rich Weiss, chief investment officer for multi-asset strategies, said the firm was neutral on emerging markets.
“EM equities have endured a difficult period of late. But even as equity prices declined, the outlook for earnings growth brightened along with prospects of a global recovery. However, China’s ongoing economic and regulatory challenges create uncertainty in the space,” he said.
“As a result, we remain neutral on the asset class, preferring to rely on individual security selection decisions to identify opportunities in our EM allocation.”
Weiss particularly highlighted problems in China which had a regulatory crackdown last year and a property crisis caused by the failure of China’s second-largest developer Evergrande at the end of the year.
“We still face uncertainty around China’s energy policy, corporate regulations and the fate of its leading property development companies. Such uncertainty and potential volatility argue against overexuberance and for sticking to a well-diversified approach,” Weiss said.
“Falling home prices and mounting challenges for China-based real estate developers threaten to weaken China’s economic growth outlook.”
The report added inflation would also be a factor to watch in 2022 and that it was “uneven” between the different emerging markets.
“While rising prices are generally the trend throughout the world, inflation in some EM countries remains relatively subdued. For example, prices are ticking higher in China, but the annual inflation rate remains relatively low compared with other markets,” Weiss said,
“Meanwhile, Turkey, Brazil and Argentina are battling double-digit inflation rates. In addition to rising energy prices, monetary policy and currency devaluations have contributed to these soaring inflation rates”.
However, there were still reasons for optimism for emerging markets including improved access to vaccines, rising commodity prices and the ability to contain virus outbreaks which would prevent economic disruption.
AUTHOR
Laura Dew
Recommended for you
Clime Investment Management has faced shareholder backlash around “unsatisfactory” financial results and is enacting cost reductions to return the business to profitability by Q1 2025.
Ausbil has expanded its distribution team with the hire of a manager for investment research and consulting, following the exit of its head of wholesale distribution in July.
Amid a growing appetite for alternatives, investment executives have shared questions advisers should consider when selecting a private markets product compared to their listed counterparts.
Chief executive Maria Lykouras is set to exit JBWere as the bank confirms it is “evolving” its operations for high-net-worth clients.
